Health Care & Life Sciences » Biotechnology | Revive Therapeutics Ltd.

Revive Therapeutics Ltd. | Balance Sheet

Fiscal year is July-June. All values CAD Thousands.
2014
2015
2016
2017
2018
Cash & Short Term Investments
1,188.90
2,492.10
1,333.20
1,768.70
1,060.50
Total Accounts Receivable
61.60
46.30
-
2.50
-
Other Current Assets
25.60
45.10
17.00
126.20
25.80
Total Current Assets
1,276.10
2,583.50
1,350.20
1,897.30
1,086.30
Net Property, Plant & Equipment
10.50
8.00
7.50
5.70
5.60
Intangible Assets
56.20
74.90
29.40
20.70
28.50
Total Assets
1,342.80
2,666.40
1,387.10
1,923.70
1,120.40
Other Current Liabilities
77.80
304.40
818.40
308.50
Total Current Liabilities
77.80
304.40
818.40
308.50
Total Liabilities
77.80
304.40
818.40
308.50
Common Equity (Total)
1,265.00
2,362.00
568.60
1,615.20
Total Shareholders' Equity
1,265.00
2,362.00
568.60
1,615.20
Total Equity
1,265.00
2,362.00
568.60
1,615.20
Liabilities & Shareholders' Equity
1,342.80
2,666.40
1,387.10
1,923.70

About Revive Therapeutics

View Profile
Address
5 Director Court
Vaughan Ontario L4L 4S5
Canada
Employees -
Website http://www.revivethera.com
Updated 07/08/2019
Revive Therapeutics Ltd. engages in the research, development, and commercialization of novel therapies and technologies for the medical cannabis and cannabinoid pharmaceuticals markets. It identifies and investigate potential therapies targeting the endocannabinoid system, such as cannabinoids. The company was founded by Fabio Chianelli on March 27, 2012 and is headquartered in Vaughan, Canada.